中国伤残医学2024,Vol.32Issue(18) :8-11.DOI:10.13214/j.cnki.cjotadm.2024.018.003

补肾活血汤联合注射用重组特立帕肽治疗肾虚血瘀型绝经后骨质疏松症患者的效果

Effect of Bushen Huoxue Decoction Combined with Recombinant Teripartide for Injection in the Treatment of Patients with Postmenopausal Osteoporosis of Kidney Deficiency and Blood Stasis Type

孙龙飞
中国伤残医学2024,Vol.32Issue(18) :8-11.DOI:10.13214/j.cnki.cjotadm.2024.018.003

补肾活血汤联合注射用重组特立帕肽治疗肾虚血瘀型绝经后骨质疏松症患者的效果

Effect of Bushen Huoxue Decoction Combined with Recombinant Teripartide for Injection in the Treatment of Patients with Postmenopausal Osteoporosis of Kidney Deficiency and Blood Stasis Type

孙龙飞1
扫码查看

作者信息

  • 1. 湖南中医药大学第二附属医院骨伤一科,湖南 长沙 410000
  • 折叠

摘要

目的:探讨补肾活血汤联合注射用重组特立帕肽治疗肾虚血瘀型绝经后骨质疏松症(PMO)患者的效果.方法:选取2022年1月—2024年1月湖南中医药大学第二附属医院收治的82例肾虚血瘀型PMO患者为研究对象,按随机数字表法分为对照组和研究组,各 41例.对照组采用注射用重组特立帕肽治疗,研究组在对照组基础上联合补肾活血汤治疗.比较两组临床疗效、骨密度、骨代谢指标、生活质量及不良反应发生情况.结果:研究组治疗有效率为 95.12%,高于对照组的80.49%,差异有统计学意义(P<0.05).治疗后,研究组腰椎骨、股骨的骨密度及骨钙素、Ⅰ型原胶原C-端前肽、特异性碱性磷酸酶水平均高于对照组,研究组世卫组织生活简易量表各维度评分均高于对照组,差异均有统计学意义(P<0.05).研究组的不良反应发生率为 9.76%,相较于对照组的 7.32%,差异无统计学意义(P>0.05).结论:补肾活血汤联合注射用重组特立帕肽治疗肾虚血瘀型PMO患者,有助于提高疗效,增加骨密度,纠正骨代谢指标,改善生活质量,且安全可靠.

Abstract

Objective:To investigate the curative effect of Bushen Huoxue Decoction combined with Recombinant Teriparatide for injection in the treatment of patients with postmenopausal osteoporosis(PMO)with kidney deficiency and blood stasis.Methods:A total of 82 PMO patients with kidney deficiency and blood stasis type admitted to the Second Affiliated Hospital of Hunan University of Chinese Medicine from January 2022 to January 2024 were selected as the study objects,and were divided into a control group and a study group according to random number table method,with 41 cases in each group.The control group was treated with Recombinant Teriparatide for injection,and the study group was treated with Bushen Huoxue Decoction based on the control group.The clinical efficacy,bone mineral density,bone metabolism index,quality of life and the occurrence of adverse reactions were compared between the two groups.Results:The effective rate of the study group was 95.12%,higher than 80.49%of the control group,the difference was statistically significant(P<0.05).After treatment,the bone density of lumbar vertebule and femur,the levels of osteocalcin,type Ⅰ procollagen C-terminal propeptide and specific alkaline phosphatase in the study group were higher than those of the control group,and the scores of all dimensions of the WHO Simple Living Scale in the study group were higher than those of the control group,with statistical significance(P<0.05).The incidence of adverse reactions in the study group was 9.76%,compared with 7.32%in the control group,the difference was not statistically significant(P>0.05).Conclusion:Bushen Huoxue Decoction combined with Recombinant Teriparatide for injection in the treatment of PMO patients with kidney deficiency and blood stasis is helpful to improve the curative effect,increase bone mineral density,correct bone metabolism indexes,improve quality of life,and is safe and reliable.

关键词

绝经后骨质疏松症/肾虚血瘀型/补肾活血汤/注射用重组特立帕肽/骨密度/生活质量

Key words

Postmenopausal osteoporosis/Kidney deficiency and blood stasis type/Bushen Huoxue Decoction/Recombinant teripartide for injection/Bone density/Quality of life

引用本文复制引用

出版年

2024
中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
段落导航相关论文